Navigation Links
National Quality Forum Endorses Six Measures for Melanoma and Eye Care
Date:11/5/2009

WASHINGTON, Nov. 5 /PRNewswire-USNewswire/ -- The National Quality Forum (NQF) has endorsed six measures to improve quality of eye and skin care in the ambulatory setting. The endorsed measures address melanoma and eye care, specifically glaucoma, macular degeneration, and cataracts.

Melanoma. The American Cancer Society estimates that about 68,720 new melanomas will be diagnosed in the United States during 2009. Although melanoma accounts for less than five percent of skin cancer cases, it causes a large majority of skin cancer deaths. The first new NQF-endorsed(R) standard for melanoma focuses on coordination of care and is intended to measure the clinician managing the melanoma, regardless of specialty. This standard aligns with the National Priorities Partnership's priority of improving care coordination. The second new NQF-endorsed standard for melanoma aligns with the National Priority of reducing overuse, targeting appropriate use of diagnostic imaging studies. The measure developer noted that melanoma care costs $240 million year, and as much as 50 percent is related to routine imaging ordered by a host of providers, including dermatologist and primary care physicians.

Eye care. The new NQF-endorsed standards for cataracts focus on complications and visual acuity following cataract surgery. According to the National Eye Institute and Prevent Blindness America (2002), cataracts affect nearly 20.5 million Americans age 40 and older. Other new NQF-endorsed standards for eye care address counseling for age-related macular degeneration, which is anticipated to affect almost 3 million people in the United States by 2020, and treatment and plan of care for glaucoma, the leading cause of blindness among African-Americans.

NQF's steering committee on eye care and melanoma measures in the ambulatory setting was co-chaired by Jeffery Kang, senior vice president, clinical programs and policy at CIGNA, and Alice Stollenwerk Petrulis, chief medical officer at KePRO.

NQF is a voluntary consensus standards-setting organization. Any party may request reconsideration of the recommendations, in whole or in part, by notifying NQF in writing via e-mail no later than December 4 (appeals@qualityforum.org). For an appeal to be considered, the notification e-mail must include information clearly demonstrating that the appellant has interests that are directly and materially affected by the NQF-endorsed recommendations and that the NQF decision has had (or will have) an adverse effect on those interests.

The mission of the National Quality Forum is to improve the quality of American healthcare by setting national priorities and goals for performance improvement, endorsing national consensus standards for measuring and publicly reporting on performance, and promoting the attainment of national goals through education and outreach programs. NQF, a non-profit organization (www.qualityforum.org) with diverse stakeholders across the public and private health sectors, was established in 1999 and is based in Washington, DC.

SOURCE National Quality Forum


'/>"/>
SOURCE National Quality Forum
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... compare student test score performance for the 2015-16 school year across Wisconsin’s public ... programs. Though it highlights important patterns in student test score performance, the report’s ...
(Date:4/25/2017)... ... 25, 2017 , ... As pharmaceutical companies are held to ... process innovation in drug formulation and manufacturing. CoreRx offers its clients more ... in support of their development and manufacturing goals. , The company was ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the ... or chronic problems, I focus on preventative care with all my patients to alleviate possible ... questions, always feel free to contact my office and my trained staff will assist you ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced that it will be participating ... Conference at the InterContinental Hotel in Boston, ... Biomet will present at 11:20 a.m. Eastern Time. ... accessed via Zimmer Biomet,s Investor Relations website at ...
(Date:4/20/2017)... -- Research and Markets has announced the addition of ... Expanding Injectables Market and Increasing Usage of Complex Biologics during the ... ... from USD 20 Billion in 2015 to around USD 26 Billion ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
Breaking Medicine Technology: